A Registration Study to Evaluate the Performance of CHIRON® RIBA® HCV 3.0 SIA in HCV Antibody Detection

TerminatedOBSERVATIONAL
Enrollment

795

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

January 31, 2013

Conditions
Hepatitis C
Trial Locations (4)

100039

302 military hospital of China, Beijing

100050

National institues for Food and Drug control, Beijing

100852

Chinese PLA general hospital, Beijing

200027

Ruijin hospital Shanghai Jiaotong University school of medicine, Shanghai

All Listed Sponsors
lead

Johnson & Johnson Medical, China

INDUSTRY